provider_review · verified 2026-09-02
NEUVÉ Health review
A page titled "Transparent pricing" that blurs its own grid behind a members-only overlay
NEUVÉ publishes $217 a month as a floor and no second NAD+ figure anywhere. Its pricing grid sits in the page text but is visually blurred behind a members-only overlay.
How this site makes money
Plain version: a handful of the outbound links here are affiliate or referral links. Follow one, start a treatment or buy a product, and we may earn a commission — your price stays exactly the same. That money pays for the research, and what we write about any product — and the price you pay — are the same either way. Want the specifics? Read the full disclosure.
at_a_glance
- price
- "STARTING AT" $217 a month on the NAD+ product page, restated as a starting-at estimate on the peptides programs page.
- what you pay
- No monthly rate can be filed. $217 is a floor and no second NAD+ figure exists anywhere on the site.
- pharmacy
- No pharmacy is named. A 503A/503B designation is stated on the NAD+ page.
- states
- The about page says care in all 50 states, and the start-care page says available to U.S. residents in all 50 states.
- on our index
- Ranked #45 of 48 on our NAD+ provider index.
verdict
The short version
NEUVÉ publishes $217 a month for NAD+ and qualifies it "starting at" on both surfaces that carry it. No second NAD+ figure exists anywhere on the site — no dose tier, no plan menu, nothing to bound what the floor rises to. Its pricing page is titled "Transparent pricing" and then blurs the grid behind a members-only overlay: the figures sit in the page text, so an automated reader would call them published while a person looking at the screen cannot read them. Which of those is the truth matters, and on a page making a transparency claim it matters more. The NAD+ card and the terms also disagree on whether the evaluation is included. We are not paid by NEUVÉ.
evidence
What the evidence for this route shows
The route sold here is a subcutaneous injection. No published randomized human trial shows meaningful energy or focus benefit from injected NAD+; the human evidence that exists sits with the oral NR precursor. See our evidence review.
pricing
What it actually costs
- advertised
- "STARTING AT" $217 a month on the NAD+ product page, restated as a starting-at estimate on the peptides programs page.
- you pay
- No monthly rate can be filed. $217 is a floor and no second NAD+ figure exists anywhere on the site.
- the catch
- The pricing page is titled "Transparent pricing" and blurs its grid behind a members-only overlay, so the numbers are present in the page text but not readable on screen.
Other money you will meet
- The NAD+ card and the terms disagree on whether the evaluation is included in the price
source :: read at neuvemd.com on 2026-09-02, in a browser that runs JavaScript.
fit
Who this is and is not for
Buy it if
- You want the entry figure readable before any intake, on two separate surfaces
- You want a 503A/503B designation stated on the NAD+ page itself
- You want coverage stated as all 50 states on more than one surface
Look elsewhere if
- You want to know what the floor rises to — no second figure exists
- You want the pricing page to show pricing without a membership
- You want a straight answer on whether the evaluation is included
included
What is inside the price
- consult
- Contradicted. The NAD+ card and the site's terms give different answers on whether the evaluation is included.
- labs
- Not included — the NAD+ page states baseline measures without pricing them.
- follow-ups
- Claimed as unlimited, with no hours or cadence published.
- human support
- Claimed as unlimited, with no hours published.
- supplies
- Not itemized.
- shipping
- Included — the only item stated as covered without qualification.
the_knock
What they would rather you skipped
A page titled "Transparent pricing" that blurs its own grid behind a members-only overlay is making a claim its layout contradicts. The figures are in the page text, so a scraper reports them as published and a reader cannot see them — and "published" should mean what a person can read, not what a parser can reach. On top of that, the NAD+ card and the terms give different answers on whether the evaluation is part of the price.
And the rest
- No second NAD+ figure exists, so the floor has nothing behind it to bound the real cost
- The page titled "Transparent pricing" blurs its own grid behind a members-only overlay
- The NAD+ card and the terms contradict each other on whether the evaluation is included
- We earn nothing on it — there is no affiliate relationship here
tools
Work out your own number
Every figure on this page was read on NEUVÉ Health’s own site on 2026-09-02 in a browser that runs JavaScript, and prices change without notice. Compare it against the rest of the field on our NAD+ provider index, or read every provider review.
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.